CYAD
Income statement / Annual
Last year (2023), Celyad Oncology SA's total revenue was $102,000.00,
and the percentage change from the previous year is not available.
In 2023, Celyad Oncology SA's net income was -$8.45 M.
See Celyad Oncology SA’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$102,000.00
|
$0.00
|
$0.00
|
$5,000.00
|
$6,000.00
|
$3.12 M
|
$3.54 M
|
$8.52 M
|
$3,000.00
|
$146,000.00
|
| Cost of Revenue |
$69,000.00 |
$1.44 M |
$1.52 M |
$0.00 |
$0.00 |
$0.00 |
$515,000.00 |
$53,000.00 |
$6.38 M |
$115,000.00 |
| Gross Profit |
$33,000.00 |
-$1.44 M |
-$1.52 M |
$5,000.00 |
$6,000.00 |
$3.12 M |
$3.03 M |
$8.47 M |
-$6.38 M |
$31,000.00 |
| Gross Profit Ratio |
0.32 |
0 |
0 |
1 |
1 |
1 |
0.85 |
0.99 |
-2126.33 |
0.21 |
| Research and Development
Expenses |
$4.67 M
|
$18.93 M
|
$20.77 M
|
$21.59 M
|
$25.23 M
|
$23.58 M
|
$22.91 M
|
$27.68 M
|
$5.90 M
|
$15.87 M
|
| General & Administrative
Expenses |
$5.71 M
|
$10.34 M
|
$9.67 M
|
$9.00 M
|
$8.73 M
|
$10.39 M
|
$9.31 M
|
$9.74 M
|
$7.23 M
|
$5.02 M
|
| Selling & Marketing
Expenses |
$215,000.00
|
$239,000.00
|
$434,000.00
|
$454,000.00
|
$607,000.00
|
$676,000.00
|
$761,000.00
|
$728,000.00
|
$891,000.00
|
$394,000.00
|
| Selling, General &
Administrative Expenses |
$6.25 M
|
$10.34 M
|
$9.67 M
|
$9.00 M
|
$8.73 M
|
$10.39 M
|
$9.31 M
|
$9.74 M
|
$7.23 M
|
$5.02 M
|
| Other Expenses |
-$2.43 M |
-$9.00 M |
-$3.53 M |
-$4.34 M |
-$4.58 M |
$7.32 M |
-$23.79 M |
-$2.52 M |
-$222,000.00 |
-$963,000.00 |
| Operating Expenses |
$8.49 M |
$20.26 M |
$26.91 M |
$26.24 M |
$29.38 M |
$41.29 M |
$29.63 M |
$34.08 M |
$29.68 M |
$19.92 M |
| Cost And Expenses |
$8.56 M |
$20.26 M |
$26.91 M |
$26.24 M |
$29.38 M |
$41.29 M |
$30.14 M |
$34.13 M |
$29.68 M |
$20.03 M |
| Interest Income |
$30,000.00 |
$12,000.00 |
$27,000.00 |
$51,000.00 |
$92,000.00 |
$804,000.00 |
$933,000.00 |
$2.20 M |
$542,000.00 |
$277,000.00 |
| Interest Expense |
$84,000.00 |
$197,000.00 |
$255,000.00 |
$297,000.00 |
$343,000.00 |
$62,000.00 |
$4.45 M |
$207,000.00 |
$236,000.00 |
$22,000.00 |
| Depreciation &
Amortization |
$794,000.00
|
$1.44 M
|
$1.52 M
|
$1.83 M
|
$1.79 M
|
$1.11 M
|
$1.71 M
|
$1.52 M
|
$1.03 M
|
$870,000.00
|
| EBITDA |
-$7.76 M
|
-$39.70 M
|
-$25.41 M
|
-$15.73 M
|
-$27.45 M
|
-$36.56 M
|
-$55.70 M
|
-$21.99 M
|
-$28.07 M
|
-$15.32 M
|
| EBITDA Ratio |
-76.11 |
0 |
0 |
-4838.4 |
-4575 |
-12 |
-4.71 |
-2.57 |
-9281.67 |
-123.59 |
| Operating Income Ratio
|
-82.91
|
0
|
0
|
-5247.8
|
-4895.5
|
-12.25
|
-14.94
|
-3
|
-9890.67
|
-112.58
|
| Total Other
Income/Expenses Net |
-$54,000.00
|
-$13,000.00
|
-$111,000.00
|
-$217,000.00
|
$239,000.00
|
$433,000.00
|
-$3.52 M
|
$2.00 M
|
$558,000.00
|
-$16,000.00
|
| Income Before Tax |
-$8.51 M |
-$40.87 M |
-$26.50 M |
-$17.20 M |
-$28.64 M |
-$37.43 M |
-$56.40 M |
-$23.61 M |
-$29.11 M |
-$16.45 M |
| Income Before Tax Ratio
|
-83.44
|
0
|
0
|
-3440.8
|
-4773.33
|
-12.02
|
-15.93
|
-2.77
|
-9704.67
|
-112.69
|
| Income Tax Expense |
-$191,000.00 |
$65,000.00 |
$10,000.00 |
$297,000.00 |
-$8,000.00 |
-$1.11 M |
-$1,000.00 |
-$6,000.00 |
-$55,000.00 |
-$2.48 M |
| Net Income |
-$8.45 M |
-$40.94 M |
-$26.51 M |
-$17.50 M |
-$28.63 M |
-$36.31 M |
-$56.40 M |
-$23.61 M |
-$29.11 M |
-$16.45 M |
| Net Income Ratio |
-82.82 |
0 |
0 |
-3500.2 |
-4772 |
-11.66 |
-15.93 |
-2.77 |
-9704.67 |
-112.69 |
| EPS |
-0.33 |
-1.81 |
-1.7 |
-1.26 |
-2.29 |
-3.26 |
-5.86 |
-2.53 |
-3.43 |
-2.44 |
| EPS Diluted |
-0.33 |
-1.81 |
-1.7 |
-1.26 |
-2.29 |
-3.26 |
-5.86 |
-2.53 |
-3.43 |
-2.44 |
| Weighted Average Shares
Out |
$25.72 M
|
$22.59 M
|
$15.60 M
|
$13.94 M
|
$12.52 M
|
$11.14 M
|
$9.62 M
|
$9.31 M
|
$8.48 M
|
$6.75 M
|
| Weighted Average Shares
Out Diluted |
$25.72 M
|
$22.59 M
|
$15.60 M
|
$13.94 M
|
$12.52 M
|
$11.14 M
|
$9.62 M
|
$9.33 M
|
$8.49 M
|
$6.75 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
